AHA ACLS PROVIDER ACTUAL VERIFIED EXAM 2026/2027 | AMERICAN HEART ASSOCIATION | VERIFIED Q&A
VERIFIED QUESTIONS | HEALTHCARE PROFESSIONALS AND ACLS CANDIDATES | AHA
AHA ACLS
PROVIDER
2026/2027
AHA ACLS Provider Actual Verified Exam 2026/2027
Verified Questions American Heart Association (AHA) - 2026/2027
2026/2027 | Verified Q&A | Healthcare Professionals and Advanced
Cardiovascular Life Support Candidates | AHA ACLS Provider
150Q VERIFIED NEWEST EXAM RATIONALES
AHA ACLS 2026/2027 AHA ACLS
INCLUDES:
• BLS, ACLS Algorithms, Cardiac Arrest, Tachycardia, Bradycardia, Stroke, ACS
• Airway Management, Pharmacology, Defibrillation, Team Dynamics, MegaCode
• 150 Verified Questions + Answers + Detailed Rationales | AHA ACLS Provider
• Professional Study Guide | Borders + Page Numbers | AHA 2026/2027 Edition
AHA ACLS Provider Actual Verified Exam | American Heart Association | Not affiliated
Confidential Study Guide - Educational Purposes Only | 2026/2027 Edition
,BLS High-Quality CPR ACLS Algorithms Cardiac Arrest Tachycardia Bradycardia AHA ACLS
Description: BLS Basic Life Support foundation ACLS Provider high-quality CPR key components rate 100 to 120 compressions per minute, depth 2 to 2.4 inches 5 to 6 cm
adults, full chest recoil allow complete recoil between compressions, minimal interruptions chest compression fraction greater than 80 percent, ventilation 30 compressions
to 2 breaths single rescuer 15 to 2 two-rescuer child infant, bag-mask device 2 breaths 1 second each visible chest rise, AED Automated External Defibrillator use as soon
as available analyze shock, team CPR switch compressor every 2 minutes fatigue, ACLS algorithms American Heart Association Advanced Cardiovascular Life Support
algorithms adult cardiac arrest algorithm VF Pulseless Ventricular Tachycardia Ventricular Fibrillation chaotic irregular no pulse shockable rhythm treatment immediate
high-quality CPR defibrillation biphasic 120 to 200 joules monophasic 360 joules, drug epinephrine 1 mg IV IO every 3 to 5 minutes vasopressor, amiodarone 300 mg first
dose antiarrhythmic 150 mg second or lidocaine 1 to 1.5 mg per kg, reversible causes H's and T's Hypovolemia Hypoxia Hydrogen ion acidosis Hyper Hypokalemia
Hypothermia Tension pneumothorax Tamponade Toxins Thrombosis pulmonary coronary, PEA Pulseless Electrical Activity organized electrical rhythm ECG without pulse
non-shockable treatment high-quality CPR epinephrine 1 mg q3 to 5 min H's T's search, Asystole flatline no electrical activity same as PEA non-shockable no shock,
tachycardia algorithms differentiate stable vs unstable unstable signs hypotension altered mental shock chest pain acute heart failure unstable tachycardia immediate
synchronized cardioversion, stable tachycardia narrow QRS less than 120 ms regular SVT Supraventricular Tachycardia vagal maneuvers adenosine 6 mg rapid IV push
then 12 mg, AFib Atrial Fibrillation irregular narrow rate control, wide QRS greater than 120 ms regular VT Ventricular Tachycardia stable amiodarone 150 mg, irregular
wide consider AFib with aberrancy, bradycardia algorithm symptomatic bradycardia HR less than 50 bpm with hypotension altered mental chest pain heart failure unstable
atropine 1 mg IV up to 3 doses first-line, if atropine ineffective transcutaneous pacing TCP or dopamine infusion 5 to 20 mcg per kg per min or epinephrine infusion 2 to 10
mcg per min, AHA ACLS Provider.
ACS Stroke Airway Pharmacology Defibrillation Team Dynamics MegaCode AHA ACLS
Description: ACS Acute Coronary Syndrome algorithm chest pain suspected ACS 12-lead ECG within 10 minutes, STEMI ST Elevation Myocardial Infarction ST elevation
in 2 contiguous leads treatment MONA Morphine Oxygen if hypoxemic Nitrates if not contraindicated hypotension RV infarct Aspirin 162 to 325 mg chewed, anticoagulant
heparin, cath lab activation door-to-balloon less than 90 minutes PCI percutaneous coronary intervention, NSTEMI Unstable Angina management, stroke algorithm
suspected stroke FAST Face drooping Arm weakness Speech difficulty Time to call, assessment Cincinnati Prehospital Stroke Scale, 12-lead CT scan rule out
hemorrhage, ischemic stroke if within window tPA tissue Plasminogen Activator alteplase inclusion exclusion criteria 3 to 4.5 hours blood pressure control, airway
management basic maneuvers head tilt chin lift if no trauma jaw thrust if trauma suspected, OPA Oropharyngeal Airway unconscious no gag NPA Nasopharyngeal Airway
semi-conscious, bag-mask ventilation 15 L oxygen 2-person technique E-C clamp, advanced airway endotracheal intubation ETT confirmation primary secondary clinical
bilateral breath sounds chest rise secondary capnography ETCO2 waveform quantitative, supraglottic airway LMA Laryngeal Mask Airway King tube, ventilation
capnography end-tidal CO2 ETCO2 target 35 to 45 post-ROSC 35 to 40, ACLS pharmacology vasopressors epinephrine alpha beta agonist vasoconstriction increased
coronary cerebral perfusion 1 mg IV IO q3 to 5 min cardiac arrest infusion 0.1 to 0.5 mcg per kg per min bradycardia hypotension, antiarrhythmics amiodarone Class III K
channel blocker VF pulseless VT stable VT 300 mg bolus then 150 mg, lidocaine Class IB alternative 1 to 1.5 mg per kg, atropine anticholinergic bradycardia 1 mg up to 3
doses max 3 mg, magnesium sulfate torsades de pointes polymorphic VT hypomagnesemia 1 to 2 g IV, beta blockers calcium channel blockers, defibrillation
unsynchronized shock random timing during cardiac cycle VF pulseless VT pulseless, energy biphasic 120 to 200 J escalating monophasic 360 J, technique clear patient
oxygen before shock, cardioversion synchronized shock timed to QRS complex avoids T wave vulnerable period SVT Atrial Fibrillation Atrial Flutter stable VT unstable
tachycardia, energy SVT AFib 50 to 100 J biphasic 120 to 200 J, VT 100 J, sedation if time, safety remove oxygen, team dynamics high-performance team roles team
leader directs compressor does compressions airway manages airway monitor defibrillator operates AED defibrillator IV IO access medications, communication closed-loop
repeat back SBAR Situation Background Assessment Recommendation mutual respect, debriefing, MegaCode scenarios integrated skills testing cardiac arrest VF PEA
asystole tachycardia bradycardia, post-cardiac arrest care ROSC Return of Spontaneous Circulation care TTM Targeted Temperature Management 32 to 36 C 24 hours
oxygenation ventilation hemodynamic optimization MAP greater than 65, coronary reperfusion 12-lead, special situations drowning hypothermia overdose pregnancy, AHA
ACLS Provider 2026/2027.
AHA ACLS Provider Exam Domains Healthcare Professionals Advanced Cardiovascular Life Support
Description: AHA American Heart Association ACLS Provider course Advanced Cardiovascular Life Support for healthcare professionals physicians nurses paramedics
respiratory therapists, objective assessment written exam 50 questions plus MegaCode skills test, domains BLS Basic Life Support 10 percent high-quality CPR AED,
ACLS Algorithms 30 percent cardiac arrest VF VT PEA asystole tachycardia bradycardia ACS stroke, Pharmacology 15 percent epinephrine amiodarone lidocaine atropine
magnesium dopamine, Airway Management 10 percent basic advanced ETCO2, Electrical Therapy 10 percent defibrillation cardioversion pacing, Team Dynamics
MegaCode 35 percent high-performance teams communication, post-cardiac arrest care special situations, AHA ACLS Provider Manual 2020/2025 Guidelines for CPR and
Emergency Cardiovascular Care ECC, American Heart Association Guidelines, 2026/2027 academic year actual verified exam 150Q verified questions answers rationales
for healthcare professionals and advanced cardiovascular life support candidates, ACLS core emergency cardiovascular care, BLS high-quality CPR compressions 100 to
120 depth 2 to 2.4 inches ventilation 30 to 2 AED, ACLS algorithms VF pulseless VT shock CPR epinephrine amiodarone PEA asystole epinephrine H's T's tachycardia
stable unstable cardioversion adenosine bradycardia atropine pacing ACS STEMI 12-lead MONA cath lab stroke FAST CT tPA airway basic advanced capnography
pharmacology defibrillation unsynchronized biphasic 120 to 200 cardioversion synchronized 50 to 200 team dynamics roles closed-loop MegaCode post-ROSC TTM,
healthcare professionals exam preparation, AHA ACLS Provider certification 2 years eCard, study guide borders page numbers improved cover page confidential
educational purposes, AHA ACLS Provider Actual Verified Exam.
Page 2 - AHA ACLS Provider 150Q 2026/2027
,Question 1: Q1: BLS and high-quality CPR - compressions and ventilation?
A. BLS Basic Life Support high-quality CPR compressions 100-120 rate 2-2.4 inches depth full recoil minimal interruptions, ventilation 30:2 2 rescuers,
AED
B. Only compressions BLS high-quality CPR
C. Only AED BLS high-quality CPR
D. No ventilation BLS high-quality CPR
CORRECT ANSWER: A. BLS Basic Life Support high-quality CPR compressions 100-120 rate 2-2.4 inches depth full recoil minimal
interruptions, ventilation 30:2 2 rescuers, AED
RATIONALE:
Rationale: BLS Basic Life Support high-quality CPR compressions 100-120 rate 2-2.4 inches depth full recoil minimal interruptions, ventilation 30:2 2 rescuers, AED. Per
American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life
support candidates 2026/2027.
Question 2: Q2: ACLS algorithms - cardiac arrest VF pulseless VT PEA asystole?
A. Only PEA ACLS algorithms cardiac arrest
B. Only VF ACLS algorithms cardiac arrest
C. ACLS algorithms cardiac arrest VF Ventricular Fibrillation pulseless VT shock CPR epinephrine amiodarone, PEA Pulseless Electrical Activity asystole
epinephrine CPR H's T's
D. No H's T's ACLS algorithms cardiac arrest
CORRECT ANSWER: C. ACLS algorithms cardiac arrest VF Ventricular Fibrillation pulseless VT shock CPR epinephrine amiodarone, PEA
Pulseless Electrical Activity asystole epinephrine CPR H's T's
RATIONALE:
Rationale: ACLS algorithms cardiac arrest VF Ventricular Fibrillation pulseless VT shock CPR epinephrine amiodarone, PEA Pulseless Electrical Activity asystole
epinephrine CPR H's T's. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals
and advanced cardiovascular life support candidates 2026/2027.
Question 3: Q3: Tachycardia and bradycardia algorithms - stable unstable?
A. Only cardioversion tachycardia bradycardia algorithms
B. Only unstable tachycardia bradycardia algorithms
C. No atropine tachycardia bradycardia algorithms
D. Tachycardia stable vs unstable tachy wide narrow QRS SVT AFib VT, unstable cardioversion, stable adenosine, bradycardia unstable atropine pacing
CORRECT ANSWER: D. Tachycardia stable vs unstable tachy wide narrow QRS SVT AFib VT, unstable cardioversion, stable adenosine,
bradycardia unstable atropine pacing
RATIONALE:
Rationale: Tachycardia stable vs unstable tachy wide narrow QRS SVT AFib VT, unstable cardioversion, stable adenosine, bradycardia unstable atropine pacing. Per
American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life
support candidates 2026/2027.
Question 4: Q4: ACS and stroke algorithms - STEMI and ischemic stroke?
A. Only STEMI ACS stroke algorithms
B. ACS Acute Coronary Syndrome STEMI ST elevation 12-lead cath lab MONA morphine oxygen nitro aspirin, stroke FAST assessment CT tPA
C. Only tPA ACS stroke algorithms
D. No MONA ACS stroke algorithms
CORRECT ANSWER: B. ACS Acute Coronary Syndrome STEMI ST elevation 12-lead cath lab MONA morphine oxygen nitro aspirin, stroke
FAST assessment CT tPA
RATIONALE:
Rationale: ACS Acute Coronary Syndrome STEMI ST elevation 12-lead cath lab MONA morphine oxygen nitro aspirin, stroke FAST assessment CT tPA. Per American
Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life support
candidates 2026/2027.
Question 5: Q5: Airway management - basic advanced and ventilation?
A. Airway management basic head tilt chin lift jaw thrust OPA NPA bag-mask, advanced ETT supraglottic LMA, ventilation capnography ETCO2
B. Only basic airway management
C. Only advanced airway management
D. No capnography airway management
CORRECT ANSWER: A. Airway management basic head tilt chin lift jaw thrust OPA NPA bag-mask, advanced ETT supraglottic LMA,
ventilation capnography ETCO2
RATIONALE:
Rationale: Airway management basic head tilt chin lift jaw thrust OPA NPA bag-mask, advanced ETT supraglottic LMA, ventilation capnography ETCO2. Per American
Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life support
candidates 2026/2027.
Question 6: Q6: ACLS pharmacology - epinephrine amiodarone atropine?
A. Only amiodarone ACLS pharmacology
B. Only epinephrine ACLS pharmacology
C. ACLS pharmacology epinephrine vasopressor 1 mg q3-5 min cardiac arrest, amiodarone antiarrhythmic VF VT 300 mg, atropine bradycardia 1 mg,
lidocaine, magnesium
D. No atropine ACLS pharmacology
CORRECT ANSWER: C. ACLS pharmacology epinephrine vasopressor 1 mg q3-5 min cardiac arrest, amiodarone antiarrhythmic VF VT 300
mg, atropine bradycardia 1 mg, lidocaine, magnesium
RATIONALE:
Page 3 - AHA ACLS Provider 150Q 2026/2027
, Rationale: ACLS pharmacology epinephrine vasopressor 1 mg q3-5 min cardiac arrest, amiodarone antiarrhythmic VF VT 300 mg, atropine bradycardia 1 mg, lidocaine,
magnesium. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced
cardiovascular life support candidates 2026/2027.
Question 7: Q7: Defibrillation and cardioversion - energy and safety?
A. Only cardioversion defibrillation cardioversion
B. Only defibrillation defibrillation cardioversion
C. No clear defibrillation cardioversion
D. Defibrillation unsynchronized shock VF pulseless VT biphasic 120-200 monophasic 360, cardioversion synchronized shock SVT AFib VT unstable,
safety clear oxygen
CORRECT ANSWER: D. Defibrillation unsynchronized shock VF pulseless VT biphasic 120-200 monophasic 360, cardioversion synchronized
shock SVT AFib VT unstable, safety clear oxygen
RATIONALE:
Rationale: Defibrillation unsynchronized shock VF pulseless VT biphasic 120-200 monophasic 360, cardioversion synchronized shock SVT AFib VT unstable, safety clear
oxygen. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced
cardiovascular life support candidates 2026/2027.
Question 8: Q8: Team dynamics and MegaCode - roles and communication?
A. Only team leader team dynamics MegaCode
B. Team dynamics roles team leader compressor airway monitor defibrillator, communication closed-loop SBAR, debriefing, MegaCode scenarios
integrated
C. Only closed-loop team dynamics MegaCode
D. No MegaCode team dynamics MegaCode
CORRECT ANSWER: B. Team dynamics roles team leader compressor airway monitor defibrillator, communication closed-loop SBAR,
debriefing, MegaCode scenarios integrated
RATIONALE:
Rationale: Team dynamics roles team leader compressor airway monitor defibrillator, communication closed-loop SBAR, debriefing, MegaCode scenarios integrated. Per
American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life
support candidates 2026/2027.
Question 9: Q9: Post-cardiac arrest care and special situations?
A. Post-cardiac arrest care ROSC Return Spontaneous Circulation TTM Targeted Temperature Management oxygenation ventilation hemodynamics,
special situations drowning hypothermia overdose pregnancy
B. Only ROSC post-cardiac arrest care special situations
C. Only TTM post-cardiac arrest care special situations
D. No hypothermia post-cardiac arrest care special situations
CORRECT ANSWER: A. Post-cardiac arrest care ROSC Return Spontaneous Circulation TTM Targeted Temperature Management oxygenation
ventilation hemodynamics, special situations drowning hypothermia overdose pregnancy
RATIONALE:
Rationale: Post-cardiac arrest care ROSC Return Spontaneous Circulation TTM Targeted Temperature Management oxygenation ventilation hemodynamics, special
situations drowning hypothermia overdose pregnancy. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for
healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 10: Q10: AHA ACLS Provider exam domains - healthcare professionals?
A. Only algorithms AHA ACLS Provider exam domains
B. Only BLS AHA ACLS Provider exam domains
C. AHA ACLS Provider exam domains BLS 10 percent ACLS algorithms 30 percent pharmacology 15 percent airway 10 percent team dynamics
MegaCode 35 percent healthcare professionals
D. No MegaCode AHA ACLS Provider exam domains
CORRECT ANSWER: C. AHA ACLS Provider exam domains BLS 10 percent ACLS algorithms 30 percent pharmacology 15 percent airway 10
percent team dynamics MegaCode 35 percent healthcare professionals
RATIONALE:
Rationale: AHA ACLS Provider exam domains BLS 10 percent ACLS algorithms 30 percent pharmacology 15 percent airway 10 percent team dynamics MegaCode 35
percent healthcare professionals. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare
professionals and advanced cardiovascular life support candidates 2026/2027.
Page 4 - AHA ACLS Provider 150Q 2026/2027
VERIFIED QUESTIONS | HEALTHCARE PROFESSIONALS AND ACLS CANDIDATES | AHA
AHA ACLS
PROVIDER
2026/2027
AHA ACLS Provider Actual Verified Exam 2026/2027
Verified Questions American Heart Association (AHA) - 2026/2027
2026/2027 | Verified Q&A | Healthcare Professionals and Advanced
Cardiovascular Life Support Candidates | AHA ACLS Provider
150Q VERIFIED NEWEST EXAM RATIONALES
AHA ACLS 2026/2027 AHA ACLS
INCLUDES:
• BLS, ACLS Algorithms, Cardiac Arrest, Tachycardia, Bradycardia, Stroke, ACS
• Airway Management, Pharmacology, Defibrillation, Team Dynamics, MegaCode
• 150 Verified Questions + Answers + Detailed Rationales | AHA ACLS Provider
• Professional Study Guide | Borders + Page Numbers | AHA 2026/2027 Edition
AHA ACLS Provider Actual Verified Exam | American Heart Association | Not affiliated
Confidential Study Guide - Educational Purposes Only | 2026/2027 Edition
,BLS High-Quality CPR ACLS Algorithms Cardiac Arrest Tachycardia Bradycardia AHA ACLS
Description: BLS Basic Life Support foundation ACLS Provider high-quality CPR key components rate 100 to 120 compressions per minute, depth 2 to 2.4 inches 5 to 6 cm
adults, full chest recoil allow complete recoil between compressions, minimal interruptions chest compression fraction greater than 80 percent, ventilation 30 compressions
to 2 breaths single rescuer 15 to 2 two-rescuer child infant, bag-mask device 2 breaths 1 second each visible chest rise, AED Automated External Defibrillator use as soon
as available analyze shock, team CPR switch compressor every 2 minutes fatigue, ACLS algorithms American Heart Association Advanced Cardiovascular Life Support
algorithms adult cardiac arrest algorithm VF Pulseless Ventricular Tachycardia Ventricular Fibrillation chaotic irregular no pulse shockable rhythm treatment immediate
high-quality CPR defibrillation biphasic 120 to 200 joules monophasic 360 joules, drug epinephrine 1 mg IV IO every 3 to 5 minutes vasopressor, amiodarone 300 mg first
dose antiarrhythmic 150 mg second or lidocaine 1 to 1.5 mg per kg, reversible causes H's and T's Hypovolemia Hypoxia Hydrogen ion acidosis Hyper Hypokalemia
Hypothermia Tension pneumothorax Tamponade Toxins Thrombosis pulmonary coronary, PEA Pulseless Electrical Activity organized electrical rhythm ECG without pulse
non-shockable treatment high-quality CPR epinephrine 1 mg q3 to 5 min H's T's search, Asystole flatline no electrical activity same as PEA non-shockable no shock,
tachycardia algorithms differentiate stable vs unstable unstable signs hypotension altered mental shock chest pain acute heart failure unstable tachycardia immediate
synchronized cardioversion, stable tachycardia narrow QRS less than 120 ms regular SVT Supraventricular Tachycardia vagal maneuvers adenosine 6 mg rapid IV push
then 12 mg, AFib Atrial Fibrillation irregular narrow rate control, wide QRS greater than 120 ms regular VT Ventricular Tachycardia stable amiodarone 150 mg, irregular
wide consider AFib with aberrancy, bradycardia algorithm symptomatic bradycardia HR less than 50 bpm with hypotension altered mental chest pain heart failure unstable
atropine 1 mg IV up to 3 doses first-line, if atropine ineffective transcutaneous pacing TCP or dopamine infusion 5 to 20 mcg per kg per min or epinephrine infusion 2 to 10
mcg per min, AHA ACLS Provider.
ACS Stroke Airway Pharmacology Defibrillation Team Dynamics MegaCode AHA ACLS
Description: ACS Acute Coronary Syndrome algorithm chest pain suspected ACS 12-lead ECG within 10 minutes, STEMI ST Elevation Myocardial Infarction ST elevation
in 2 contiguous leads treatment MONA Morphine Oxygen if hypoxemic Nitrates if not contraindicated hypotension RV infarct Aspirin 162 to 325 mg chewed, anticoagulant
heparin, cath lab activation door-to-balloon less than 90 minutes PCI percutaneous coronary intervention, NSTEMI Unstable Angina management, stroke algorithm
suspected stroke FAST Face drooping Arm weakness Speech difficulty Time to call, assessment Cincinnati Prehospital Stroke Scale, 12-lead CT scan rule out
hemorrhage, ischemic stroke if within window tPA tissue Plasminogen Activator alteplase inclusion exclusion criteria 3 to 4.5 hours blood pressure control, airway
management basic maneuvers head tilt chin lift if no trauma jaw thrust if trauma suspected, OPA Oropharyngeal Airway unconscious no gag NPA Nasopharyngeal Airway
semi-conscious, bag-mask ventilation 15 L oxygen 2-person technique E-C clamp, advanced airway endotracheal intubation ETT confirmation primary secondary clinical
bilateral breath sounds chest rise secondary capnography ETCO2 waveform quantitative, supraglottic airway LMA Laryngeal Mask Airway King tube, ventilation
capnography end-tidal CO2 ETCO2 target 35 to 45 post-ROSC 35 to 40, ACLS pharmacology vasopressors epinephrine alpha beta agonist vasoconstriction increased
coronary cerebral perfusion 1 mg IV IO q3 to 5 min cardiac arrest infusion 0.1 to 0.5 mcg per kg per min bradycardia hypotension, antiarrhythmics amiodarone Class III K
channel blocker VF pulseless VT stable VT 300 mg bolus then 150 mg, lidocaine Class IB alternative 1 to 1.5 mg per kg, atropine anticholinergic bradycardia 1 mg up to 3
doses max 3 mg, magnesium sulfate torsades de pointes polymorphic VT hypomagnesemia 1 to 2 g IV, beta blockers calcium channel blockers, defibrillation
unsynchronized shock random timing during cardiac cycle VF pulseless VT pulseless, energy biphasic 120 to 200 J escalating monophasic 360 J, technique clear patient
oxygen before shock, cardioversion synchronized shock timed to QRS complex avoids T wave vulnerable period SVT Atrial Fibrillation Atrial Flutter stable VT unstable
tachycardia, energy SVT AFib 50 to 100 J biphasic 120 to 200 J, VT 100 J, sedation if time, safety remove oxygen, team dynamics high-performance team roles team
leader directs compressor does compressions airway manages airway monitor defibrillator operates AED defibrillator IV IO access medications, communication closed-loop
repeat back SBAR Situation Background Assessment Recommendation mutual respect, debriefing, MegaCode scenarios integrated skills testing cardiac arrest VF PEA
asystole tachycardia bradycardia, post-cardiac arrest care ROSC Return of Spontaneous Circulation care TTM Targeted Temperature Management 32 to 36 C 24 hours
oxygenation ventilation hemodynamic optimization MAP greater than 65, coronary reperfusion 12-lead, special situations drowning hypothermia overdose pregnancy, AHA
ACLS Provider 2026/2027.
AHA ACLS Provider Exam Domains Healthcare Professionals Advanced Cardiovascular Life Support
Description: AHA American Heart Association ACLS Provider course Advanced Cardiovascular Life Support for healthcare professionals physicians nurses paramedics
respiratory therapists, objective assessment written exam 50 questions plus MegaCode skills test, domains BLS Basic Life Support 10 percent high-quality CPR AED,
ACLS Algorithms 30 percent cardiac arrest VF VT PEA asystole tachycardia bradycardia ACS stroke, Pharmacology 15 percent epinephrine amiodarone lidocaine atropine
magnesium dopamine, Airway Management 10 percent basic advanced ETCO2, Electrical Therapy 10 percent defibrillation cardioversion pacing, Team Dynamics
MegaCode 35 percent high-performance teams communication, post-cardiac arrest care special situations, AHA ACLS Provider Manual 2020/2025 Guidelines for CPR and
Emergency Cardiovascular Care ECC, American Heart Association Guidelines, 2026/2027 academic year actual verified exam 150Q verified questions answers rationales
for healthcare professionals and advanced cardiovascular life support candidates, ACLS core emergency cardiovascular care, BLS high-quality CPR compressions 100 to
120 depth 2 to 2.4 inches ventilation 30 to 2 AED, ACLS algorithms VF pulseless VT shock CPR epinephrine amiodarone PEA asystole epinephrine H's T's tachycardia
stable unstable cardioversion adenosine bradycardia atropine pacing ACS STEMI 12-lead MONA cath lab stroke FAST CT tPA airway basic advanced capnography
pharmacology defibrillation unsynchronized biphasic 120 to 200 cardioversion synchronized 50 to 200 team dynamics roles closed-loop MegaCode post-ROSC TTM,
healthcare professionals exam preparation, AHA ACLS Provider certification 2 years eCard, study guide borders page numbers improved cover page confidential
educational purposes, AHA ACLS Provider Actual Verified Exam.
Page 2 - AHA ACLS Provider 150Q 2026/2027
,Question 1: Q1: BLS and high-quality CPR - compressions and ventilation?
A. BLS Basic Life Support high-quality CPR compressions 100-120 rate 2-2.4 inches depth full recoil minimal interruptions, ventilation 30:2 2 rescuers,
AED
B. Only compressions BLS high-quality CPR
C. Only AED BLS high-quality CPR
D. No ventilation BLS high-quality CPR
CORRECT ANSWER: A. BLS Basic Life Support high-quality CPR compressions 100-120 rate 2-2.4 inches depth full recoil minimal
interruptions, ventilation 30:2 2 rescuers, AED
RATIONALE:
Rationale: BLS Basic Life Support high-quality CPR compressions 100-120 rate 2-2.4 inches depth full recoil minimal interruptions, ventilation 30:2 2 rescuers, AED. Per
American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life
support candidates 2026/2027.
Question 2: Q2: ACLS algorithms - cardiac arrest VF pulseless VT PEA asystole?
A. Only PEA ACLS algorithms cardiac arrest
B. Only VF ACLS algorithms cardiac arrest
C. ACLS algorithms cardiac arrest VF Ventricular Fibrillation pulseless VT shock CPR epinephrine amiodarone, PEA Pulseless Electrical Activity asystole
epinephrine CPR H's T's
D. No H's T's ACLS algorithms cardiac arrest
CORRECT ANSWER: C. ACLS algorithms cardiac arrest VF Ventricular Fibrillation pulseless VT shock CPR epinephrine amiodarone, PEA
Pulseless Electrical Activity asystole epinephrine CPR H's T's
RATIONALE:
Rationale: ACLS algorithms cardiac arrest VF Ventricular Fibrillation pulseless VT shock CPR epinephrine amiodarone, PEA Pulseless Electrical Activity asystole
epinephrine CPR H's T's. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals
and advanced cardiovascular life support candidates 2026/2027.
Question 3: Q3: Tachycardia and bradycardia algorithms - stable unstable?
A. Only cardioversion tachycardia bradycardia algorithms
B. Only unstable tachycardia bradycardia algorithms
C. No atropine tachycardia bradycardia algorithms
D. Tachycardia stable vs unstable tachy wide narrow QRS SVT AFib VT, unstable cardioversion, stable adenosine, bradycardia unstable atropine pacing
CORRECT ANSWER: D. Tachycardia stable vs unstable tachy wide narrow QRS SVT AFib VT, unstable cardioversion, stable adenosine,
bradycardia unstable atropine pacing
RATIONALE:
Rationale: Tachycardia stable vs unstable tachy wide narrow QRS SVT AFib VT, unstable cardioversion, stable adenosine, bradycardia unstable atropine pacing. Per
American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life
support candidates 2026/2027.
Question 4: Q4: ACS and stroke algorithms - STEMI and ischemic stroke?
A. Only STEMI ACS stroke algorithms
B. ACS Acute Coronary Syndrome STEMI ST elevation 12-lead cath lab MONA morphine oxygen nitro aspirin, stroke FAST assessment CT tPA
C. Only tPA ACS stroke algorithms
D. No MONA ACS stroke algorithms
CORRECT ANSWER: B. ACS Acute Coronary Syndrome STEMI ST elevation 12-lead cath lab MONA morphine oxygen nitro aspirin, stroke
FAST assessment CT tPA
RATIONALE:
Rationale: ACS Acute Coronary Syndrome STEMI ST elevation 12-lead cath lab MONA morphine oxygen nitro aspirin, stroke FAST assessment CT tPA. Per American
Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life support
candidates 2026/2027.
Question 5: Q5: Airway management - basic advanced and ventilation?
A. Airway management basic head tilt chin lift jaw thrust OPA NPA bag-mask, advanced ETT supraglottic LMA, ventilation capnography ETCO2
B. Only basic airway management
C. Only advanced airway management
D. No capnography airway management
CORRECT ANSWER: A. Airway management basic head tilt chin lift jaw thrust OPA NPA bag-mask, advanced ETT supraglottic LMA,
ventilation capnography ETCO2
RATIONALE:
Rationale: Airway management basic head tilt chin lift jaw thrust OPA NPA bag-mask, advanced ETT supraglottic LMA, ventilation capnography ETCO2. Per American
Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life support
candidates 2026/2027.
Question 6: Q6: ACLS pharmacology - epinephrine amiodarone atropine?
A. Only amiodarone ACLS pharmacology
B. Only epinephrine ACLS pharmacology
C. ACLS pharmacology epinephrine vasopressor 1 mg q3-5 min cardiac arrest, amiodarone antiarrhythmic VF VT 300 mg, atropine bradycardia 1 mg,
lidocaine, magnesium
D. No atropine ACLS pharmacology
CORRECT ANSWER: C. ACLS pharmacology epinephrine vasopressor 1 mg q3-5 min cardiac arrest, amiodarone antiarrhythmic VF VT 300
mg, atropine bradycardia 1 mg, lidocaine, magnesium
RATIONALE:
Page 3 - AHA ACLS Provider 150Q 2026/2027
, Rationale: ACLS pharmacology epinephrine vasopressor 1 mg q3-5 min cardiac arrest, amiodarone antiarrhythmic VF VT 300 mg, atropine bradycardia 1 mg, lidocaine,
magnesium. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced
cardiovascular life support candidates 2026/2027.
Question 7: Q7: Defibrillation and cardioversion - energy and safety?
A. Only cardioversion defibrillation cardioversion
B. Only defibrillation defibrillation cardioversion
C. No clear defibrillation cardioversion
D. Defibrillation unsynchronized shock VF pulseless VT biphasic 120-200 monophasic 360, cardioversion synchronized shock SVT AFib VT unstable,
safety clear oxygen
CORRECT ANSWER: D. Defibrillation unsynchronized shock VF pulseless VT biphasic 120-200 monophasic 360, cardioversion synchronized
shock SVT AFib VT unstable, safety clear oxygen
RATIONALE:
Rationale: Defibrillation unsynchronized shock VF pulseless VT biphasic 120-200 monophasic 360, cardioversion synchronized shock SVT AFib VT unstable, safety clear
oxygen. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced
cardiovascular life support candidates 2026/2027.
Question 8: Q8: Team dynamics and MegaCode - roles and communication?
A. Only team leader team dynamics MegaCode
B. Team dynamics roles team leader compressor airway monitor defibrillator, communication closed-loop SBAR, debriefing, MegaCode scenarios
integrated
C. Only closed-loop team dynamics MegaCode
D. No MegaCode team dynamics MegaCode
CORRECT ANSWER: B. Team dynamics roles team leader compressor airway monitor defibrillator, communication closed-loop SBAR,
debriefing, MegaCode scenarios integrated
RATIONALE:
Rationale: Team dynamics roles team leader compressor airway monitor defibrillator, communication closed-loop SBAR, debriefing, MegaCode scenarios integrated. Per
American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare professionals and advanced cardiovascular life
support candidates 2026/2027.
Question 9: Q9: Post-cardiac arrest care and special situations?
A. Post-cardiac arrest care ROSC Return Spontaneous Circulation TTM Targeted Temperature Management oxygenation ventilation hemodynamics,
special situations drowning hypothermia overdose pregnancy
B. Only ROSC post-cardiac arrest care special situations
C. Only TTM post-cardiac arrest care special situations
D. No hypothermia post-cardiac arrest care special situations
CORRECT ANSWER: A. Post-cardiac arrest care ROSC Return Spontaneous Circulation TTM Targeted Temperature Management oxygenation
ventilation hemodynamics, special situations drowning hypothermia overdose pregnancy
RATIONALE:
Rationale: Post-cardiac arrest care ROSC Return Spontaneous Circulation TTM Targeted Temperature Management oxygenation ventilation hemodynamics, special
situations drowning hypothermia overdose pregnancy. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for
healthcare professionals and advanced cardiovascular life support candidates 2026/2027.
Question 10: Q10: AHA ACLS Provider exam domains - healthcare professionals?
A. Only algorithms AHA ACLS Provider exam domains
B. Only BLS AHA ACLS Provider exam domains
C. AHA ACLS Provider exam domains BLS 10 percent ACLS algorithms 30 percent pharmacology 15 percent airway 10 percent team dynamics
MegaCode 35 percent healthcare professionals
D. No MegaCode AHA ACLS Provider exam domains
CORRECT ANSWER: C. AHA ACLS Provider exam domains BLS 10 percent ACLS algorithms 30 percent pharmacology 15 percent airway 10
percent team dynamics MegaCode 35 percent healthcare professionals
RATIONALE:
Rationale: AHA ACLS Provider exam domains BLS 10 percent ACLS algorithms 30 percent pharmacology 15 percent airway 10 percent team dynamics MegaCode 35
percent healthcare professionals. Per American Heart Association AHA ACLS Provider Manual and 2020/2025 AHA Guidelines for CPR and ECC for healthcare
professionals and advanced cardiovascular life support candidates 2026/2027.
Page 4 - AHA ACLS Provider 150Q 2026/2027
